EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A interseção da genética e da medicina personalizada no tratamento de doenças cardiovasculares: desafios e oportunidades.

Gabriela Zirondi Rigolon, Diego Rego Rodrigues da Silva, João Pedro Gomes de Barros, Lucas Rosendo da Silva

Revista ft · 03.07.2026 · 30 (160) · 01-15

DOI: 10.69849/ent1hf48 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista ft, online erschienen am 03.07.2026. Verfasst von Gabriela Zirondi Rigolon und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Personalized medicine has stood out as an innovative approach in the treatment of various diseases, especially cardiovascular diseases, whose prevalence and mortality remain high on a global scale. The integration of genetic advancements with clinical practice has enabled the development of more effective therapeutic strategies based on the individual biological profile of each patient. This transformation, however, faces challenges related to the structure of healthcare services, professional training, and the incorporation of technology into medical protocols. This study aimed to analyze how genetics has contributed to the personalization of cardiovascular disease treatment, identifying the main obstacles and possibilities for its effective clinical application. To this end, a qualitative approach based on a bibliographic search was adopted, surveying articles published between 2021 and 2025 in the SciELO, PubMed, and LILACS databases. Case law (jurisprudence) available in Brazilian State Courts (TJs) from 2019 to 2023 was also consulted. Inclusion criteria considered peer-reviewed texts available in full text, while exclusion criteria encompassed materials unrelated to the core theme or unavailable in their entirety. The results showed that although scientific advancements have expanded therapeutic possibilities, structural and educational barriers still hinder the consolidation of personalized medicine in cardiology. The findings point to the need for public policies, investment in technology, and professional training as a means to expand access to and the effectiveness of this care model.

Zitieren

APA

Rigolon, G. Z., Silva, D. R. R. D., Barros, J. P. G. D., & Silva, L. R. D. (2026). A interseção da genética e da medicina personalizada no tratamento de doenças cardiovasculares: desafios e oportunidades. Revista ft, 30(160), 01-15. https://doi.org/10.69849/ent1hf48

Vancouver

Rigolon GZ, Silva DRRD, Barros JPGD, Silva LRD. A interseção da genética e da medicina personalizada no tratamento de doenças cardiovasculares: desafios e oportunidades. Revista ft. 2026;30(160):01-15. doi:10.69849/ent1hf48

BibTeX
@article{Rigolon2026,
  author = {Rigolon, Gabriela Zirondi and Silva, Diego Rego Rodrigues da and Barros, João Pedro Gomes de and Silva, Lucas Rosendo da},
  title = {A interseção da genética e da medicina personalizada no tratamento de doenças cardiovasculares: desafios e oportunidades},
  journal = {Revista ft},
  year = {2026},
  volume = {30},
  number = {160},
  pages = {01--15},
  doi = {10.69849/ent1hf48}
}
Kostenlos starten →